In the untreated AD group, the proportion of M2-type microglia—labeled by CD163—was significantly reduced in the hippocampus compared to the WT group, while the expression of cyclooxygenase-2 (COX-2), a marker of M1-type microglia, was markedly elevated. Here, CD163 is linked to Alzheimer disease.